The first enantioselective total syntheses of virosaine A and bubbiali- 
structural features of these pseudoenantiomers are characterized by their densely functionalized, stereochemically complex architecture featuring an unusual tetracyclic core incorporating a trihydro-1,2-oxazine ring. Neither 1 nor 2 showed cytotoxic activity against selected cancer cell lines (MCF-7, MDA-MB-231, HepG2, HepG2/ ADM, HL-60, K562 and Hep2). 2 Among this family of natural products, securinine (3) is the most abundant and widely spread alkaloid possessing an impressive range of biological activity including neurotransmitter gammaaminobutyric acid (GABA) receptor antagonism, 3 in vivo CNS activity and anti-malarial and anti-bacterial activities. 4, 5 Due to its remarkable biological activities and intriguing molecular structure, numerous total syntheses have been reported to date. 1b,6 Conversely, a related yet much rarer securinega alkaloid (+)-phyllantidine (4) has a similar cyclic hydroxylamine scaffold to virosaines A (1) and B (2) and only one total synthesis has been published due to its complex architecture. 7 During the preparation of this manuscript, the first total synthesis of virosaine B was reported by Yang, Li and coworkers. 8 Two other putatively related alkaloids bubbialidine (5) and bubbialine (6) were isolated from the leaves of Zygogynum pauciflorum by Potier et al. in 1990. 9 There is no reported publication for the synthesis of virosaine A and bubbialidine to date. In this communication, we report the first total syntheses of virosaine A (1) and bubbialidine (5) . Our brief retrosynthetic analysis is illustrated in Scheme 1. The main synthetic strategies are the vinylogous Mannich reaction, an intramolecular aza-Michael addition, a late-stage regioselective oxidation of the pyrrolidine moiety to the nitrone and the subsequent intramolecular [1,3]-dipolar cycloaddition. Inspired by the proposed biosynthesis of virosaines suggested by Zhang, Ye and coworkers, 2 we envisaged that nitrone 7 should undergo a stereoselective intramolecular cycloaddition to form the complex tetracyclic core 1, creating three new stereogenic centres. A regioselective oxidation could be achieved in N-hydroxypyrrolidine 8 leading to 7. Following a synthetic strategy described by Magnus et al., 10 oxidation precursor 8 should be available from tetracycle 9 through an N-oxidation-Cope elimination sequence. An intramolecular aza-Michael addition of pyrrolidinylfuranone 10 would allow the formation of 9, which will serve as a masked alkene intermediate enabling N-oxidation in the next step. Finally, a vinylogous Mannich reaction between aminol 11 and furanone 12 should provide the key intermediate 10 after t-butyloxycarbonyl (Boc) deprotection. The preparation of silyl-protected aquilegiolide (+)-12 was carried out following three reported publications (Schemes 2 and 3).
11 The synthesis started with commercially available 1,4-cyclohexadiene 13. A three step procedure involving monoepoxidation, ring-opening with cyanomethyllithium and acetylation gave the racemic acetate (AE)-14 in 22% yield. Enzymatic kinetic resolution was then employed to generate enantiomerically enriched alcohol (À)-15 and acetate (+)-14 with 94.6% ee and 96.0% ee, respectively. Scheme 4 Enantioselective synthesis of virosaine A (1).
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View Article Online revealed under slightly acidic conditions to yield N-hydroxypyrrolidine (À)-8 in 77% yield over two steps. 15 The next step was the construction of the nitrone unit 7 utilizing a convenient and mild method developed by Mukaiyama and coworkers. 16 Gratifyingly, the use of N-t-butylbenzenesulfinimidoyl chloride 21
17 at À78 1C resulted in a complete regioselective formation of nitrone 7 due to steric encumbrance and an immediate intramolecular [1,3]-dipolar cycloaddition 15a,18,19 was observed. Finally, the removal of silyl group was performed using tetrabutylammonium fluoride to give virosaine A (1) in a good yield of 81% over two steps. The synthetic virosaine A (1) displayed identical physical and spectroscopic data to those reported in the literature. 2 In addition, the first synthesis of bubbialidine (5) was also accomplished by silyl deprotection of tetracycle (À)-9 to give the target natural product in 92% yield (Scheme 5). The synthetic sample displayed identical physical and spectroscopic data to the reported values. 9 In summary, we report the first enantioselective total syntheses of virosaine A (1) and bubbialidine (5). The synthesis of virosaine A was achieved in 18 steps whereas bubbialidine was synthesized in 15 steps starting from readily available material. Our synthetic strategy can be highlighted by the intramolecular aza-Michael addition for the construction of the tetracycle (À)-9, Copeelimination for a late-stage oxidation of the pyrrolidine unit, and an intramolecular cycloaddition reaction to build the 7-oxa-1-azabicyclo[3.2.1]octane ring core. Further application of this approach towards related natural products is currently under investigation.
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